News Quantified


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

H.C. Wainwright Maintains Buy on Atai Beckley (ATAI) Following Breakthrough Therapy and Merger Completion [Yahoo! Finance]

Enhanced Fortifies Executive Leadership Team & Board of Directors

Atai Beckley N.V. (ATAI) Receives Buy Rating on BPL-003 Edge against Spravato [Yahoo! Finance]

AtaiBeckley to Participate in the Jefferies Global Healthcare Conference in London

ATAI Life Sciences GAAP EPS of -$0.28 misses by $0.17, revenue of $0.75M beats by $0.69M [Seeking Alpha]

11/12/2025

07:00 am

ATAI

1.9%

MISS

8/14/2025

07:00 am

ATAI

-0.5%

MISS

Form 4 Atai Beckley N.V. For: Nov 25 Filed by: Feilding-Mellen Cosmo

Form 10-Q Atai Beckley N.V. For: Sep 30

Form 8-K Atai Beckley N.V. For: Nov 12

Form 4 Atai Beckley N.V. For: Nov 05 Filed by: HERSHBERG ROBERT

Form 4 Atai Beckley N.V. For: Nov 05 Filed by: Feilding-Mellen Cosmo

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}